中华眼底病杂志

中华眼底病杂志

髓样细胞表达触发受体在缺血性视神经病变中的表达

查看全文

目的 观察缺血性视神经病变视神经组织中髓样细胞表达触发受体(TREM)、半胱氨酸蛋白酶(Caspase)-3、白细胞介素(IL)-6的表达。 方法 Sprague Dawley大鼠20只随机分为对照组、模型组,每组均为10只大鼠。模型组大鼠行双侧颈内动脉结扎建立亚急性缺血性视神经病变动物模型;对照组大鼠游离双侧颈总动脉,但不结扎。建模后14 d,实时定量聚合酶链反应、蛋白质免疫印迹法检测大鼠视神经组织中TREM-1、TREM-2、Caspase-3、IL-6基因及蛋白表达。 结果 与对照组比较,模型组大鼠视神经组织中TREM-1(tmRNA=6.058,t蛋白=9.671)、Caspase-3(tmRNA=7.86,t蛋白=9.524)、IL-6(tmRNA=6.055,t蛋白=14.501) mRNA和蛋白表达升高,TREM-2(tmRNA=6.992,t蛋白=9.283)mRNA和蛋白表达降低,差异均有统计学意义(P<0.05)。 结论 TREM-1基因和蛋白在缺血性视神经组织中显著表达;TREM-2基因和蛋白显著下降。

Objective To observe the expression of triggering receptor expressed on myeloid cells (TREM), Caspase-3 and interleukin (IL)-6 in optic nerve tissue of ischemic optic neuropathy (ION). Methods Twenty Sprague-Dawley rats were randomly divided into control group and model group, 10 rats in each group. The permanent ligation of bilateral internal carotid arteries (BICA) was performed for 14 days to establish sub-acute ION model as model group. The control group were separated BICA without ligation. The expressions of TREM-1, TREM-2, Caspase-3 and IL-6 in rat retina were detected by reverse transcription PCR and Western blot, respectively. ResultsCompared with the control group, the expressions of TREM-1, Caspase-3, IL-6 mRNA (t=6.058, 7.86, 6.055) and protein (t=9.671, 9.524, 14.501) in the optic nerve tissue of the model group were increased, while the expression of TREM-2 mRNA and protein (t=9.283) was decreased, and the difference was statistically significant (P<0.05). Conclusion In ischemic optic nerve tissue, TREM-1 mRNA and protein were significantly expressed, the expressions of TREM-2 mRNA and protein decreased significantly.

关键词: 视神经病变, 缺血性; 髓样细胞表达触发受体; 半胱氨酸天冬氨酸蛋白酶3; 白细胞介素6; 动物实验

Key words: Optic neuropathy, ischemic; Triggering receptors expressed by myeloid cells; Caspase-3; IL-6; Animal experimentation

引用本文: 孟凡超, 孙世龙, 苏建, 石佩玉, 周伟民, 王书香, 楚金亭. 髓样细胞表达触发受体在缺血性视神经病变中的表达. 中华眼底病杂志, 2018, 34(5): 471-474. doi: 10.3760/cma.j.issn.1005-1015.2018.05.012 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Ford JW, McVicar DW. TREM and TREM-like receptors in inflammation and disease[J].Curr Opin Immunol, 2009, 21(1): 38-46. DOI:10.1016/j.coi.2009.01.009.
2. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes[J]. J Immunol, 2000, 164: 4991-4995.
3. Sieber MW, Jaenisch N, Brehm M, et al. Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2(TREM2) knock-out mice following stroke[J/OL]. PLoS One, 2013, 8(1): 52982[2013-01-03] . https://doi.org/10.1371/journal.pone.0052982. DOI:10.1371/journal.pone.0052982.
4. Takahashi K, Rochford CDP, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2[J]. Exp Med, 2005, 201(4): 647-657. DOI:10.1084/jem.20041611.
5. Kawabori M, Kacimi R, Kauppinen T, et al. Triggering receptor expressed on myeloid cells 2(TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke[J]. J Neurosci, 2015, 35(8): 3384-3396. DOI:10.1523/JNEUROSCI. 2620-14.2015.
6. Peng Q, Malhotra S, Torchia JA, et al. TREM2-and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1[J]. Sci Signal, 2010, 3(122): 38.DOI: 10.1126/scisignal.2000500.
7. Colonna M. TREMs in the immune system and beyond[J]. Nat Rev Immunol,2003, 3(6): 445- 453. DOI: 10.1038/nri1106.
8. Colonna M, Facchetti F. TREM-1(triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses[J].J Infect Dis, 2003, 187 Suppl 2:S397-401. DOI:10.1086/374754.
9. Sharif O, Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection[J]. Immunobiology, 2008, 213(9-10): 701-713. DOI:10.1111/jre.12417.
10. Fahrenhold M, Rakic S, Classey J,et al.TREM2 expression in the human brain: a marker of monocyte recruitment?[J/OL].Brain Pathol,2017,2017:E1[2017-10-07] .https://doi.org/10.1111/bpa.12564. DOI: 10.1111/bpa.12564.[published online ahead of print].
11. .Bleharski JR, Kiessler V, Buonsanti C, et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response[J]. J Immunol, 2003,170(7): 3812-3818.
12. Knapp S, Gibot S, de Vos A, et al. Cutting edge: Expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia[J].J Immunol,2004,173(12): 7131-7134.
13. Hiroyuki K, Hiroshi K. Microglial TREM2/DAP12 signaling: a double-edged sword in neural diseases[J]. Front Cell Neurosci, 2018, 12:206. DOI:org/10.3389/fncel.2018.00206.
14. Jeremie J, Stephane P, Lynda Z, et al. Genetic and pharmacological inhibition of TREM-1 limits the development of experimental atherosclerosis[J]. J Am Coll Cardiol, 2016,68(25): 2776-2793. DOI:10.1016/j.jacc.2016.10.015.
15. Ma Y,Wang J,Wang Y, et al. The biphasic function of microglia in ischemic stroke[J]. Prog Neurobiol, 2017, 157: 247-272. DOI:10.1016/j.pneurobio.2016.01.005.